APPLICATION
ANDA216772
TYPE
ANDA
ORIGINAL APPROVAL
2024-06-12
LATEST ACTION
2026-06-05
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Discontinued
Products
BRIMONIDINE TARTRATEDiscontinued
BRIMONIDINE TARTRATE 0.15% · SOLUTION/DROPS · OPHTHALMIC
Approval history
2026-06-05Labeling · Supplement 2 · standardAP
2024-06-12UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.